113 filings
Page 5 of 6
8-K
74t1z2
30 Jul 21
Virpax® Pharmaceuticals Strengthens Board of Directors with the Appointment of Gerald W. Bruce and Michael F. Dubin, CPA to its Board
9:15am
8-K
95rc0cd
18 May 21
Virpax Pharmaceuticals Reports 2021 First Quarter Results and Recent Developments
8:11am
10-Q
1vr3z0ugeta
17 May 21
Quarterly report
4:01pm
S-8
28cjm
23 Apr 21
Registration of securities for employees
4:31pm
8-K
cu3g iahli
19 Apr 21
Departure of Directors or Certain Officers
4:30pm
8-K
5ko3nq6x04cg
13 Apr 21
Departure of Directors or Certain Officers
4:30pm
10-K
iubo14is212
31 Mar 21
Annual report
4:30pm
POS EX
o6i yps0eoo
18 Feb 21
Additional exhibits for listing
4:45pm
424B4
b6ea f3h3
18 Feb 21
Prospectus supplement with pricing info
4:31pm
EFFECT
87x7 2fayqgw5xuyz
17 Feb 21
Notice of effectiveness
12:15am
S-1MEF
77mc0o
16 Feb 21
Registration of additional securities for an S-1
6:42pm
CERT
6w91j1pg
16 Feb 21
Certification of approval for exchange listing
9:37am
SEC STAFF
wfxqwd7xvxppg6
16 Feb 21
SEC staff action: Order
12:00am
8-A12B
1psze3d8 ix7r1h
11 Feb 21
Registration of securities on exchange
4:30pm
CORRESP
ngepd0o
11 Feb 21
Correspondence with SEC
12:00am
CORRESP
dk0hp3
11 Feb 21
Correspondence with SEC
12:00am
FWP
yq6e2hl fv5
8 Jan 21
Free writing prospectus
5:05pm
CORRESP
m73sj puow0yntkpqih
8 Jan 21
Correspondence with SEC
12:00am